Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling
- PMID: 18061473
- DOI: 10.1016/j.cyto.2007.09.015
Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling
Abstract
Coordinated regulation of T and B cell-mediated immune responses plays a critical role in the control and modulation of autoimmune diseases. This review is focused on the adapter molecule Act1 and its regulation of autoimmunity through its impact on both T and B cell-mediated immune responses. Whereas Act1 molecule is an important negative regulator for B cell-mediated humoral immune responses through its function in CD40L and BAFF signaling, recent studies have shown that Act1 is also a key positive signaling component for IL-17 signaling pathway, critical for T(H)17-mediated autoimmune and inflammatory responses. The dual functions of Act1 are evident in Act1-deficient mice that displayed B cell-mediated autoimmune phenotypes (including dramatic increase in peripheral B cells, lymphadenopathy and splenomegaly, hypergammaglobulinemia and Sjogren's disease in association with Lupus Nephritis), but showed resistance to T(H)17-dependent EAE and colitis. Such seemingly opposite functions of Act1 in CD40-BAFFR and IL-17R signaling are orchestrated by different domains in Act1. Whereas Act1 interacts with the IL-17R through the C-terminal SEFIR domain, Act1 is recruited to CD40 and BAFFR indirectly, which is mediated by TRAF3 through the TRAF binding site in Act1. Such delicate regulatory mechanisms may provide a common vehicle to promote balance between host defense to pathogens and tolerance to self.
Similar articles
-
Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.Immunity. 2004 Oct;21(4):575-87. doi: 10.1016/j.immuni.2004.09.001. Immunity. 2004. PMID: 15485634
-
Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome.Eur J Immunol. 2008 Aug;38(8):2219-28. doi: 10.1002/eji.200738113. Eur J Immunol. 2008. PMID: 18624351 Free PMC article.
-
A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling.Sci STKE. 2007 Aug 7;2007(398):re4. doi: 10.1126/stke.3982007re4. Sci STKE. 2007. PMID: 17684298 Review.
-
The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.Nat Immunol. 2007 Mar;8(3):247-56. doi: 10.1038/ni1439. Epub 2007 Feb 4. Nat Immunol. 2007. PMID: 17277779
-
Determinations of B cell fate in immunity and autoimmunity.Curr Dir Autoimmun. 2005;8:1-24. doi: 10.1159/000082084. Curr Dir Autoimmun. 2005. PMID: 15564715 Review.
Cited by
-
Sjögren's syndrome: studying the disease in mice.Arthritis Res Ther. 2011 Jun 13;13(3):217. doi: 10.1186/ar3313. Arthritis Res Ther. 2011. PMID: 21672284 Free PMC article. Review.
-
Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population.Immunity. 2012 May 25;36(5):821-33. doi: 10.1016/j.immuni.2012.03.021. Epub 2012 May 17. Immunity. 2012. PMID: 22608496 Free PMC article.
-
Enhanced expression of trim14 gene suppressed Sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity.Immunol Res. 2015 Jul;62(3):255-62. doi: 10.1007/s12026-015-8653-1. Immunol Res. 2015. PMID: 25948474
-
Regulatory effect of Act1 on the BAFF pathway in B-cell malignancy.Oncol Lett. 2019 Apr;17(4):3727-3734. doi: 10.3892/ol.2019.10047. Epub 2019 Feb 18. Oncol Lett. 2019. PMID: 30930983 Free PMC article.
-
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects.J Immunol Res. 2019 Feb 10;2019:7682827. doi: 10.1155/2019/7682827. eCollection 2019. J Immunol Res. 2019. PMID: 30882006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
